Dermata Therapeutics Inc (DRMA)

[The Night Stalker]

·

To elect three director nominees to serve as directors until the 2026 annual meeting of stockholders;

·

To ratify the appointment of Mayer Hoffman McCann P.C. as our independent registered public accounting firm for the year ending December 31, 2023;

·

To approve an amendment to the Dermata Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan (the “2021 Plan”) to increase the number of the shares of common stock authorized for issuance thereunder by 513,150 shares to 629,069 shares; and

·

To consider any other matters that may properly come before the Annual Meeting.



Only stockholders of record at the close of business on June 5, 2023 are entitled to receive notice of and to vote at the Annual Meeting or any postponement or adjournment thereof.